Supporting Opioid Risk Assessment with the Stratus DX Assessment Tool


Use Case:
Risk Stratification & Documentation for Chronic Opioid Therapy

Objective:
Streamline risk assessment, ensure CMS compliance, and generate documentation to support billing

Background:
To meet CMS guidelines under LCD L35724 for Controlled Substance Monitoring and Drugs of Abuse Testing, providers must document medical necessity when prescribing and monitoring opioid therapy. This includes validated risk assessments, such as the SOAPP-R and Opioid Risk Tool (ORT), and alignment with testing frequency based on patient risk level.

Solution:
Using the Stratus DX Assessment Tool, our clients are able to implement a digital workflow for capturing opioid risk assessments directly within the LIS. Clinicians administer the SOAPP-R and ORT via custom-configured surveys, and results were automatically scored and saved to the patient record.Patients identified as “high risk” were flagged within the system, triggering recommended urine drug testing frequency (1‐3 times every 3 months), in alignment with CMS protocols. Exportable reports were generated for billing and documentation, ensuring readiness for insurance audits.
Blueprint of Assessment Tool

Outcome:

  • • Reduced manual paperwork and risk of documentation errors

  • • Improved compliance with CMS testing frequency guidelines

  • • Enabled timely and defensible billing for UDT frequency guidelines (CPT codes 80305‐80307, G0480‐G0483)

  • • Enhanced visibility into patient risk over time for better care decisions

This use case demonstrates how the Assessment Tool empowers labs and providers to document opioid risk quickly, securely, and in full compliance with evolving regulatory standards.